NASDAQ:NERV

Minerva Neurosciences Stock Insider Trading

etoro logo Buy NERV
*Your capital is at risk
$4.68
-0.0700 (-1.47%)
At Close: Jun 03, 2026

Minerva Neurosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 9.17M and sold 161.75K NERV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 9.17M shares
Sell 161.75K shares
91% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 21, 2026
Buy
Common Stock
J-Other
O'connor James Joseph
Insider
Other 0
Value: $0
Apr 21, 2026
Buy
Employee Stock Option (right to buy)
A-Award
O'connor James Joseph
Chief Business Officer And GC
Officer 350 800
Value: $2.45M
Mar 31, 2026
Buy
Stock Option (right to buy)
A-Award
Kaul Inderjit
Director
Director 12 169
Value: $73.4K
Dec 22, 2025
Buy
Employee Stock Option (right to buy)
A-Award
Luthringer Remy
CEO
CEO / President 2 250 000
Value: $8.96M
Dec 22, 2025
Buy
Employee Stock Option (right to buy)
A-Award
Race Geoff
President
CEO / President 1 500 000
Value: $5.97M
Dec 22, 2025
Buy
Employee Stock Option (right to buy)
A-Award
Ahlholm Frederick W
SVP, CFO And Secretary
C-Suite Officer 500 000
Value: $1.99M
Dec 22, 2025
Buy
Stock Option (right to buy)
A-Award
Van Heek G Jan
Director
Director 50 000
Value: $199.0K
Dec 22, 2025
Buy
Stock Option (right to buy)
A-Award
Kupfer David
Director
Director 50 000
Value: $199.0K
Dec 22, 2025
Buy
Stock Option (right to buy)
A-Award
Kaul Inderjit
Director
Director 364 504
Value: $1.45M
Dec 22, 2025
Buy
Stock Option (right to buy)
A-Award
Hasler Hans Peter
Director
Director 50 000
Value: $199.0K
Dec 22, 2025
Buy
Stock Option (right to buy)
A-Award
Laghrissi-thode Fouzia
Director
Director 50 000
Value: $199.0K
Nov 14, 2025
Buy
Stock Option (right to buy)
A-Award
Kaul Inderjit
Director
Director 9 500
Value: $39.0K
Nov 14, 2025
Buy
Common Stock
J-Other
Kaul Inderjit
Insider
Other 0
Value: $0
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Van Heek G Jan
Director
Director 12 500
Value: $26.5K
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Laghrissi-thode Fouzia
Director
Director 12 500
Value: $26.5K
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Kupfer David
Director
Director 12 500
Value: $26.5K
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Hasler Hans Peter
Director
Director 12 500
Value: $26.5K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Ahlholm Frederick W
SVP, CFO And Secretary
C-Suite Officer 47 500
Value: $100.7K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Race Geoff
President
CEO / President 95 000
Value: $201.4K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Luthringer Remy
CEO
CEO / President 105 000
Value: $222.6K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Luthringer Remy
CEO
CEO / President 105 000
Value: $222.6K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Race Geoff
President
CEO / President 95 000
Value: $201.4K
Dec 05, 2024
Buy
Employee Stock Option (right to buy)
A-Award
Ahlholm Frederick W
SVP, CFO And Secretary
C-Suite Officer 47 500
Value: $100.7K
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Hasler Hans Peter
Director
Director 12 500
Value: $26.5K
Dec 05, 2024
Buy
Stock Option (right to buy)
A-Award
Kupfer David
Director
Director 12 500
Value: $26.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MINERVA NEUROSCIENCES
Minerva Neurosciences
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE